Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST 1 3 Blood Donation 4 2 5 6 7 8 9 10 11 12 Antibody specificities related to the mechanism of immune haemolytic destruction. Blood group Intravascular system haemolysis ABO,H Extra vascular haemolysis A,B,H RH All Kell K K, k, Kpa, Kpb, Jsa, Jsb Kidd Jka Jka, JKb, Jk3 Duffy Fya, Fyb MNS M,S,s,U Lutheran LUb Lewis Lea Cartwright Yta Colton Coa, Cob Dombrock Doa, Dob Glycosyltransfereases produced by genes encoding for antigens within the ABO, H, and Lewis blood group system. Gene Allele Transferase FUT1 H H α-2-L-fucosyltransferase None A A α-3-N-acetyl-D-galactosaminyltransferase B B α-3-D-galactosyltransferase O O None FUT2 Se se α-2-L-fucosyltransferase None FUT3 Le le α-3/4-L-fucosyltransferase None ABO blood group system Blood group Subgroup Antigens on red cells Antibodies in plasma A A1 A2 A + A1 A Anti-B (Anti- A1)* B - B Anti-A, Anti- A1 AB A1B A2 B A + A1 + B A+B None (Anti- A1)* O - (H)† Anti-A Anti- A1 Anti-B Anti-A,B† * Anti- A1 found in 1-2% of A2 subjects and 25-30% of A2B subjects. † The amount of H antigen is influenced by the ABO group; O cells contain most H and A1B cells least. Anit-H may be found in occasional A1 and A1B subject (see text). † Crossreactivity with both A and B cells. The “Front Type" determines which antigens ("flags") in the ABO blood group system are on the patient's Red Blood Cells as follows: A antigen only B antigen only A and B antigens Neither A or B Type A Type B Type AB Type O The “Back Type" identifies the isohaemagglutinin (Naturally Occurring Antibody) in the patient's serum and should correspond to the antigens found on the Red Blood Cells as follows: Anti-B Anti-A Anti-A and anti-B Neither anti-A or anti-B Type A Type B Type O Type AB In addition, RBCs are Rh typed and identified as "D“ positive or negative ABO Grouping -----------------------------------------Reactions of ------------------------------------Cells with Serum with ------------------------------------Anti-A Anti-B A Cells B Cells Blood Group (forward grouping) (reverse grouping) ----------------------------------------------0 0 0 + + A + 0 0 + B 0 + + 0 AB + + 0 0 The most common Rh phenotypes with possible genotypes and frequencies in an English population (accounting for >99% of all Rh genotypes in this population) 53 Reaction with anti- Phenotype/most probable genotype Possible genotypes Frequency DCe/dce/R1 DCe/dce/R1r DCe/Dce/R1RO DCe/dCe/R0r’ 32.68 2.16 0.05 + DCe/DCe/R1R1 DCe/DCe/R1R1 DCe/dCe/R1r’ 17.68 0.82 - + dce/dce rr dce/dce rr 15.10 + - + Cde/cde r’r Cde/cde r’r 0.76 - + + + cdE/cde r”r cdE/cde r”r 0.92 + + + + + DCe/DcE R1R2 DCe/DcE R1R2 DCe/dcE R1 R” DcE/dCe R2 r’ DCE/cde Rzr Dce/DCE RoRz Dce/dCE RoRy 11.87 1.00 0.28 0.19 0.01 <0.01 + - + + dCe/DCE R2r DcE/dce R2r DcE/Dce R2R0 Dce/dcE Ror” 10.97 0.73 0.06 + - + Dce/cdeR0r Dce/Dce R0R0 2.00 0.07 + - DcE/DcE R2R2 DcE/dcE R2r” 1.99 0.34 D C c E e + + + - + + + - - - - + - + - + + + - DcE/DcE R2R2 The Rh haplotypes in order of frequency (Fisher nomenclature) in caucasians and the corresponding short notations Fisher Short notations Approximate frequency (%) CDe R1 41 Cde r 39 cDE R2 14 cD3 RO 3 CwDe R1w 1 cdE r” 1 Cde r’ 1 CDE Rz Rare CdE Ry Rare ABO group and Rh type Screening for blood-group antibodies Serologic test for syphilis Serologic tests for human retroviruses including: HIV-1 antibody HIV-2 antibody HIV p24 antigen HTLV I antibodies Serologic tests for hepatitis including: Hepatitis B core antibody (HBcAb) Hepatitis B surface antigen (HBsAg) Hepatitis C antibody It determines compatibility between patient serum and donor red blood cells. A full crossmatch procedure takes about 45 minutes to complete and cannot be shortened. Units are refrigerated until used. A unit of blood MUST be properly labeled and the label MUST be checked before use. PREPARATION Predeposited: Blood is collected in the weeks prior elective surgery Haemodilution: Blood is collected immediately before surgery to be reinfused at the end of the operation Salvage: Heavy blood loss during operation is collected to be reinfused Choice of ABO group for blood products for administration to neonates and infants younger than age 4 months Infants ABO Group ABO group of blood product to be transfused Red cells Platelets FFP* O O O O A A or O† A A or AB B B or O† B† or A or O B or AB AB AB or A or B or O† AB† or A AB FFP, fresh plasma. * Only babies and infants who are blood group O should receive group O FFP because of anti-A and anti-B antibodies, whereas group AB FFP contains no naturally occurring antibodies. †Group O products must be checked for high-titre anti-A and anti-B before being given to recipients that are not group O. This is particularly important for platelets because of the relatively large volumes of plasma. •†Group B or AB platelets may not be available. Immediate Transfusion Reactions • • • • • • • • • Hemolytic Reactions Allergic Reactions Febrile Reactions Transfusion related acute lung injury (TRALI) Bacterial Contamination Circulatory Overload Citrate toxicity Air embolism Alloimmunization: • RBCs • Platelets Delayed Transfusion Reactions • Graft Versus Host Disease (GVHD) • Transfusion-associated graft versus host disease (TAGVHD) • Post-transfusion purpura • Haemosiderosis • H.D.N. Delayed Transfusion Reactions (Cont…) Transmitted Diseases Hepatitis B Hepatitis C Human Immunodeficiency Virus (HIV) Human T-lymphocytotrophic Virus (HTLV-1) Cytomegalovirus (CMV) Kaposi’s sarcoma and human herpes virus-8 (KS & HHV-8) Malaria Leishmaniasis Others: Babesiosis. Lyme disease. Chagas' disease Creutzfeldt-Jakob Disease (CJD) Toxoplasmosis Evidence of Haemolysis Examine patient’s plasma and urine for haemoglobin and its derivaties. Blood film may show spherocytosis Evidence of incompatibility Clerical checks. An identification error will indicate the type incompatibility. If no evidence of clerical error, proceed as follows: Repeat ABO and Rh D groups of patient and donor unit and screen for antibodies. Use patient’s pre-and post-transfusion samples Repeat compatibility tests, using patient’s pre-and post -transfusion serum Direct antiglobulin test on post-transfusion red cells may indicate antibody and/or complement Evidence of bacterial infection of donor blood Gram stain and culture donor blood. THANK YOU